FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Where Trump, GOP vs Democrats redistricting battle heads next in wake of key court rulings

Harris accuses Trump allies of trying to ‘rig’ 2026 midterms after Virginia court tosses redistricting measure

Minnesota nonprofit accused of siphoning $6.5M to fund Vegas trips, luxury cars, private liquor store

Alabama mother sentenced to life for hiring hitman to kill her child’s father over custody dispute

Trump warns college sports could be ‘lost forever’ as committee pushes changes, Congress urged to act

Duffys fire back after Pete Buttigieg, husband attack new road trip TV series: ‘Radical, miserable left’

Breathtaking ‘Chandelier UFO’ Video Goes Viral – But Is There a Simple Explanation?

Nearly a dozen injured after possible boat explosion at popular Florida tourist destination

Seth Moulton closing gap on progressive Democrat Ed Markey in Massachusetts Senate primary

Breaking: Bobby Cox, Manager of Braves ‘Teams That Ruled NL,’ Dead at 84

Two police officers shot, suspect ‘actively firing at police’ in Syracuse standoff lasting hours: report

Mob Attacks Indian Pastor and His Family as Villagers Try to Drive Him Away from Home

Virginia mother charged with murder after allegedly drowning her 17-month-old twin boys in bathtub: report

Shocking video shows giant black plume of smoke rising from Tennessee plastic recycling facility fire

Guess Where Hundreds of Uncounted Ballots Were Just Found in California – Hint: It’s One of Dems’ Favorite Places

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”